Effects of different mitogens on intrasplenic liver tissue transplants in comparison to orthotopic liver

Experimental and Toxicologic Pathology

Volumn 54, Issue 5-6, 2003, Pages 449-465

  Lupp, Amelie ^a   Lucas, Norma ^a   Tralls, Manuela ^a   Fuchs, Udo ^a   Danz, Manfred ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Cytochrome P450; Fluorene; Glycogen; Hepatocytes; Mitogen; Mitotic index; Spleen; Transplantation

Indexed keywords

CYTOCHROME P450 ISOENZYME; DIBENZYLAMINE; FLUORENE; FLUORENONE DERIVATIVE; GLUTATHIONE; GLYCOGEN; LIPID PEROXIDE; MITOGENIC AGENT; N (2 FLUORENYL)ACETAMIDE; SOLVENT; UNSPECIFIC MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; FETUS; GLYCOGEN LIVER LEVEL; LIVER CELL; LIVER TRANSPLANTATION; MALE; MITOSIS RATE; NONHUMAN; OXIDATION; PROTEIN EXPRESSION; RAT; SPLEEN TRANSPLANTATION; TISSUE CULTURE; TOXICITY;

ANIMALIA;

EID: 0037897333     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1078/0940-2993-00282     Document Type: Article

References (68)

1. AITIO A: A simple and sensitive assay of 7-ethoxycoumarin deethylation. Anal Biochem 1978; 85: 488-491.
2. AMBROSINO G, VAROTTO S, BASSO S, et al.: Hepatocyte transplantation: an experimental study to treat acute liver failure in pigs. Transplant Proc 2001; 33: 62-65.
3. APPEL KE, GÖRSDORF S, SCHEPER T, et al.: Metabolic denitrosation of N-nitrosamines: mechanism and biological consequences. In: O'NEILL IK, CHEN J, and BARTSCH H (eds.): Relevance to human cancer of N-nitroso compounds, tobacco smoke and mycotoxins. International Agency for Research on Cancer IARC, Lyon, 1991; pp. 351-357.
4. ARKADOPOULOS N, LILJA H, SUH KS, et al.: Intrasplenic transplantation of allogeneic hepatocytes prolongs survival in anhepatic rats. Hepatology 1998; 28: 1365-1370.
5. ASTRÖM A, DEPIERRE JW: Metabolism of 2-acetylaminofluorene by eight different forms of cytochrome P-450 isolated from rat liver. Carcinogenesis 1985; 6: 113-120.
6. ASTRÖM A, BIRBERG W, PILOTTI A, DEPIERRE JW: Induction of different isozymes of cytochrome P-450 and of microsomal epoxide hydrolase in rat liver by 2-acetylaminofluorene and structurally related compounds. Eur J Biochem 1986; 154: 125-134.
7. AYRTON AD, MCFARLANE M, WALKER R, et al.: The induction of P450 I proteins by aromatic amines may be related to their carcinogenic potential. Carcinogenesis 1990; 11: 803-809.
8. BARON J, KAWABATA T, KNAPP S, et al.: Intrahepatic distribution of xenobiotic metabolizing enzymes. In: CALDWELL J, PAULSON GD (eds.): Foreign compound metabolism. Taylor & Francis, London, 1984; pp. 17-36.
9. BAUMGARTNER D, LAPLANTE-O'NEILL PM, SUTHERLAND DER, NAJARIAN JS: Effects of intrasplenic injection of hepatocytes, hepatocyte fragments and hepatocyte culture supernatants on D-galactosamine-induced liver failure in rats. Eur Surg Res 1983; 15: 129-135.
10. BILIR BM, GUINETTE D, KARRER F, et al.: Hepatocyte transplantation in acute liver failure. Liver Transpl 2000; 6: 32-40.
11. BLASZYK H, HARTMANN A, DANZ M: Persistent proliferation of normal hepatocytes and promotion of preneoplastic development by N-nitrosodibenzylamine in rats. J Cancer Res Clin Oncol 1993; 120: 71-75.
12. CHALOUPKA K, STEINBERG M, SANTOSTEFANO M, et al.: Induction of Cyp1a-1 and Cyp1a-2 gene expression by a reconstituted mixture of polynuclear aromatic hydrocarbons in B6C3F1 mice. Chem Biol Interact 1995; 96: 207-221.
13. CHOWDHURY JR, GROSSMAN M, GUPTA S, et al.: Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDLR-deficient rabbits. Science 1991; 254: 1802-1805.
14. CIKRYT P, GÖTTLICHER M, NEUMANN HG: Competitive binding affinity of carcinogenic aromatic amines to the rat hepatic aromatic hydrocarbon (Ah) receptor in vitro and potency to induce monooxygenase activity in vivo. Carcinogenesis 1990; 11: 1359-1366.
15. CORREIA MA: Rat and human liver cytochrome P450: substrate and inhibitor specificities and functional markers. In: ORTIZ DE MONTELLANO PR (ed.): Cytochrome P450: structure, mechanism and biochemistry. Plenum Press, New York and London, 2nd edition, 1995; pp. 607-630.
16. CUERVAS-MONS V, CIENFUEGOS JA, MAGANTO P, et al.: Time-related efficacy of liver cell isografts in fulminant hepatic failure. Transplantation 1984; 38: 23-25.
17. DANZ M, HARTMANN A, OTTO M, BLASZYK H: Hitherto unknown additive growth effects of fluorene and 2-acetylaminofluorene on bile duct epithelium and hepatocytes in rats. Arch Toxicol, Suppl 1991; 14: 71-75.
18. DANZ M, MÜLLER D, RÄTHE H: Fluorenone and 2-benzoylfluorenone: different short-term effects on drug-metabolizing liver enzymes and on cell proliferation. Exp Toxic Pathol 1992; 44: 259-261.
19. DANZ M, HARTMANN A, BLASZYK H: Mitogenic short-term effects on hepatocytes and adrenocortical cells: phenobarbital and reserpine compared to carcinogenic and non-carcinogenic fluorene derivatives. Exp Toxic Pathol 1998; 50: 416-424.
20. DAVID P, ALEXANDRE E, AUDET M, et al.: Engraftment and albumin production of intrasplenically transplanted rat hepatocytes (Sprague-Dawley), freshly isolated versus cryopreserved, into Nagase analbuminemic rats (NAR). Cell Transplant 2001; 10: 67-80.
21. ELLMAN GL: Tissue sulfhydryl groups. Arch Biochem Biophys 1959; 82: 70-77.
22. Fox IJ, CHOWDHURY JR, KAUFMAN SS, et al.: Treatment of the Crigler-Najjar-syndrome Type I with hepatocyte transplantation. New Engl J Med 1998; 338: 1422-1426.
23. FRIEDMAN FK, MILLER H, PARK SS, et al.: Induction of rat liver microsomal and nuclear cytochrome P-450 by dietary 2-acetylaminofluorene and butylated hydroxytoluene. Biochem Pharmacol 1989; 38: 3075-3081.
24. GROOTHUIS GMM, MEIJER DKF, HARDONK MJ: Morphological studies on selective acinar liver damage by N-hydroxy-2-acetylaminofluorene and carbon tetrachloride. Arch Pharmacol 1983; 322: 298-300.
25. GROOTHUIS GM, HULSTAERT CE, KALICHARAN D, HARDONK MJ: Genesis of unusual vesicles in rat periportal hepatocytes after administration of N-hydroxy-2-acetylaminofluorene. Virchows Arch B Cell Pathol Incl Mol Pathol 1984; 46: 77-82.
26. HABIBULLAH CM, SYED ICH, QAMAR A, TAHER-UZ Z: Human fetal hepatocyte transplantation in patients with fulminant hepatic failure. Transplantation 1994; 58: 951-952.
27. HADJIOLOV N, BITSCH A, NEUMANN HG: Early initiating and promoting effects in 2-AAF-induced rat liver carcinogenesis: an immunohistochemical study. Cancer Lett 1995; 98: 39-46.
28. HISSIN PJ, HILF R: A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 1976; 74: 214-226.
29. IKEBUKURO H, INAGAKI M, MITO M, et al.: Prolonged function of hepatocytes transplanted into the spleens of Nagase analbuminemic rats. Eur Surg Res 1999; 31: 39-47.
30. IOANNIDES C, CHEUNG YL, WILSON J, et al.: The mutagenicity and interactions of 2- and 4-(acetylamino)fluorene with cytochrome P450 and the aromatic hydrocarbon receptor may explain the difference in their carcinogenic potency. Chem Res Toxicol 1993; 6: 535-541.
31. KATO K, KASAI S, ONODERA K, et al.: Effect of hepatocyte growth factor on the proliferation of transplanted hepatocytes in the spleen. Transpl Proc 1997; 29: 2029-2031.
32. KIM WH, LEE JH, HAN SU, et al.: Systematic analysis of the effects of hepatocyte transplantation on rats with acute liver failure. Hepatogastroenterol 2000; 47: 371-374.
33. KLINGER W, MÜLLER D: The influence of age on the protein concentration in serum, liver and kidney of rats determined by various methods. Z Versuchstierk 1974; 16: 146-153.
34. KLINGER W, MÜLLER D: Ethylmorphine N-demethylation by liver homogenate of newborn and adult rats; enzyme kinetics and age course of Vmax and Km. Acta Biol Med Germ 1977; 36: 1149-1159.
35. KOBAYASHI N, ITO M, NAKAMURA J, et al.: Treatment of carbon tetrachloride and phenobarbital-induced chronic liver failure with intrasplenic hepatocyte transplantation. Cell Transplant 2000; 9: 671-673.
36. KOKUDO N, OTSU I, OKAZAKI T, et al.: Long-term effects of intrasplenically transplanted adult hepatocytes and fetal liver in hyperbilirubinemic Gunn rats. Transpl Int 1995; 8: 262-267.
37. LAKE BG, RENWICK AB, CUNNINGHAM ME, et al.: Comparison of the effects of some CYP3A and other enzyme inducers on replicative DNA synthesis and cytochrome P450 isoforms in rat liver. Toxicol 1998; 131: 9-20.
38. LEWIS DFV: Cytochromes P450: Structure, function and mechanism. Taylor & Francis, London, 1996.
39. LINDROOS P, TSAI WH, ZARNEGAR R, MICHALOPOULOS GK: Plasma levels of HGF in rats treated with tumor promoters. Carcinogenesis 1992; 13: 139-141.
40. LOTLIKAR PD: Metabolic activation of aromatic amines and dialkylnitrosamines. J Cancer Res Clin Oncol 1981; 99: 125-136.
41. LOTLIKAR PD, PANDEY RN, CLEARFIELD MS, PAIK SM: Oxidative activation and inactivation of the carcinogen 2-acetylaminofluorene by various purified cytochromes P-450 from 3-methylcholanthrene pretreated rats. Toxicol Lett 1984; 21: 111-118.
42. LUBET RA, MAYER RT, CAMERON JW, et al.: Dealkylation of pentoxyresorufin: a rapid and sensitive assay for measuring induction of cytochrome(s) P-450 by phenobarbital and other xenobiotics in rat. Arch Biochem Biophys 1985; 238: 43-48.
43. LUPP A, LUCAS N, LINDSTRÖM-SEPPÄ P, et al.: Developmental expression of cytochrome P450 isoforms after transplantation of fetal liver tissue suspension into the spleens of adult syngenic rats. Exp Toxic Pathol 1998a; 50: 41-51.
44. LUPP A, LUCAS N, LINDSTRÖM-SEPPÄ P, et al.: Transplantation of fetal liver tissue suspension into the spleens of adult syngenic rats: Effects of β-naphthoflavone, phenobarbital and dexamethasone on cytochrome P450 isoforms expression and on glycogen storage. Exp Toxic Pathol 1998b; 50: 173-183.
45. LUPP A, TRAUTMANN AK, KRAUSSE T, KLINGER W: Developmental changes of cytochrome P450 dependent monooxygenase functions after transplantation of fetal liver tissue suspension into spleens of adult rats. Exp Toxic Pathol 1998c; 50: 239-244.
46. LUPP A, LAU K, TRAUTMANN AK, et al.: Transplantation of fetal liver tissue suspension into the spleens of adult syngenic rats: inducibility of cytochrome P450 dependent monooxygenase functions by β-naphthoflavone, phenobarbital and dexamethasone. Exp Toxic Pathol 1999; 51: 65-74.
47. MAKOWKA L, ROTSTEIN LE, FALK JA, et al.: Reversal of toxic and anoxic induced hepatic failure by syngenic, allogenic and xenogenic hepatocyte transplantation. Surgery 1980; 88: 244-253.
48. MATAS AJ, SUTHERLAND DER, STEFFES MW, et al.: Hepatocellular transplantation in UDP-glucuronyltransferase deficient rats. Surg Forum 1975; 26: 428-431.
49. MATAS AJ, SUTHERLAND DER, STEFFES MW, et al.: Hepatocellular transplantation for metabolic deficiencies: decrease of plasma bilirubin in Gunn rats. Science 1976; 192: 892-894.
50. MITO M, KUSANO M: Hepatocyte transplantation in man. Cell Transplant 1993; 2: 65-74.
51. OKOCHI E, MOCHIZUKI M: Dealkylation of N-nitrosodibenzylamine by metalloporphyrin/oxidant model systems for cytochrome P450. Chem Pharm Bull 1995; 43: 2173-2176.
52. POHL RJ, FOUTS JR: A rapid method for assaying the metabolism of 7-ethoxyresorufin by microsomal subcellular fractions. Anal Biochem 1980; 107: 150-155.
53. RATANASAVANH D, BEAUNE P, MOREL F, et al.: Intralobular distribution and quantitation of cytochrome P-450 enzymes in human liver as a function of age. Hepatology 1991; 13: 1142-1151.
54. RIBEIRO J, NORDLINGER B, BALLET F, et al.: Intrasplenic hepatocellular transplantation corrects hepatic encephalopathy in portocaval-shunted rats. Hepatology 1992; 15: 12-18.
55. SCHMEZER P, POOL BL, LEFEVRE PA, et al.: Assay-specific genotoxicity of the non-carcinogen N-nitrosodibenzylamine to the rat liver in vivo. Environ Mol Mutagen 1990; 15: 190-197.
56. SIERRA E, MAGANTO P, CODESAL J, et al.: Liver gene expression and increase in albumin synthesis by fetal hepatocytes transplanted into analbuminemic rats. Life Sci 2000; 67: 2417-2432.
57. SMOLOWITZ RM, HAHN ME, STEGEMAN JJ: Immunohistochemical localization of cytochrome P-450IA1 induced by 3,3′,4,4′-tetrachlorobiphenyl and by 2,3,7,8-tetrachlorodibenzofuran in liver and extrahepatic tissues of the teleost Stenotomus chrysops (scup). Drug Metab Dispos 1991; 19: 113-123.
58. SOMMER BG, SUTHERLAND DER, MATAS AJ, et al.: Hepatocellular transplantation for treatment of D-galactosamine-induced acute liver failure in rats. Transplant Proc 1979; 11: 578-584.
59. STROM SC, FISHER RA, THOMPSON MT, et al.: Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure. Transplantation 1997; 63: 559-569.
60. STROM SC, CHOWDHURY JR, FOX IJ: Hepatocyte transplantation for the treatment of human disease. Semin Liver Dis 1999; 19: 39-48.
61. SUTHERLAND DER, NUMATA M, MATAS AJ, et al.: Hepatocellular transplantation in acute liver failure. Surgery 1977a; 82: 124-132.
62. SUTHERLAND DER, MATAS AJ, STEFFES MW, et al.: Transplantation of liver cells in an animal model of congenital enzyme deficiency disease: the Gunn rat. Transplant Proc 1977b; 9: 317-319.
63. THORGEIRSSON SS, MITCHELL JR, SASAME HA, POTTER WZ: Biochemical changes after hepatic injury by allyl alcohol and N-hydroxy-2-acetylaminofluorene. Chem Biol Interact 1976; 15: 139-147.
64. WIEDERKEHR JC, KONDOS GT, POLLAK R: Hepatocyte transplantation for the low-density lipoprotein receptordeficient state. Transplantation 1990; 50: 466-476.
65. WOLF CR, MOLL E, FRIEDBERG T, et al.: Characterization, localization and regulation of a novel phenobarbital-inducible form of cytochrome P-450, compared with three further P-450 isoenzymes, NADPH P-450 reductase, glutathione transferases and microsomal epoxide hydrolases. Carcinogenesis 1984; 5: 993-1001.
66. XIANGDONG W, AR'RAJAB A, AHREN B, et al.: Improvement of the effects of intrasplenic transplantation of hepatocytes after 90% hepatectomy in the rat by cotransplantation with pancreatic islets. Transplantation 1991; 52: 462-466.
67. YAGI K: Lipid peroxides and human diseases. Chem Phys Lipids 1987; 45: 337-351.
68. ZHANG H, MIESCHER-CLEMENS E, DRUGAS G, et al.: Intrahepatic hepatocyte transplantation following subtotal hepatectomy in the recipient: a possible model in the treatment of hepatic enzyme deficiency. J Pediatr Surg 1992; 27: 312-315.